Abstract:Abstract GVHD is the major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. We developed a consistent and sensitive model of human GVHD by retroorbitally (ro) injecting huT cells into sublethally irradiated NOD/SCID-β2mnull mice (β2). Using this model, 59% (20/34) mice conditioned with 250cGy and injected ro with 107 huT cells developed lethal XGVHD and exhibited huT cell engraftment, weight loss, and infiltration in multiple target tissues. β2 mice injected with huT through the lateral tail vein (iv) had only small and transient huT cell engraftment and failed to develop lethal XGVHD. To evaluate why the ro versus iv route affected huT cell engraftment and the development of lethal XGVHD, we performed in vivo BLI and sequential [18F]FHBG microPET imaging studies. We used huT cells transduced with a click beetle red luciferase/enhanced green fluorescent protein (CBRluc/egfp) BLI reporter gene (huT*) and/or a chimeric CD34-thymidine kinase fusion suicide/PET gene. We injected 107 huT* cells either iv or ro into 250cGy irradiated β2 mice. Mice injected iv (n=5) failed to develop lethal XGVHD, whereas 60% of the mice injected ro (n=5) developed lethal XGVHD. During the first week, mice injected ro presented early expansion of the huT cells in the retroorbital cavity and local regional draining lymph nodes followed by widespread dissemination throughout the whole body, with increased percentage of huT in the blood (p<0.04), and lost significant body weight (p<0.02) in comparison to mice injected iv. Serial BLI revealed very different trafficking and expansion profiles between the two routes of administration. HuT*cells injected iv immediately trafficked to the lungs and failed to expand during the first 3 weeks. In contrast, the ro-injected cells remained in the ro cavity and trafficked to secondary lymphoid organs during the first week. This altered trafficking of the ro-injected cells was associated with >10-fold increase in the BLI signal during the first 2 weeks. This homing pattern and strong BLI signal of the ro-injected huT* cells remained until death from GVHD. The BLI signal of the iv-injected huT* cells increased between days 21 and 45. However, this late expansion was not associated with the development of XGVHD. We also generated huT cells that co-expressed the suicide gene CD34-TK75 and CBRluc/egfp (huT**). We observed the same results after we injected 0.25×107 huT** cells into 250cGy irradiated and anti-CD122 mAb-treated NOD/SCID mice followed with BLI and PET. These studies demonstrated the ability to image trafficking of the transduced T cells in vivo with BLI and PET. In summary, all mice that received huT iv showed initial clearing of the huT cells in the lungs and a significant delay in their in vivo expansion abrogating their potential to cause XGVHD. In contrast, the development of lethal XGVHD in immunodeficient mice was dependent upon the initial retention and early expansion of huT in the retroorbital cavity.

X‐ray irradiation effectively inactivated lymphocytes in transfusion in vivo monitored by the bioluminescence transfusion‐associated graft‐versus‐host disease model

Irradiation of Blood Components to Prevent Transfusion-Associated Graft-Versus-host Disease in Immunological Deficient Patients with Hematological Malignances

Effects of X-rays and Γ-Rays on Reconstitution of Hematopoiesis and Immunity after Allogeneic Bone Marrow Transplantation

Influence of the lentiviral vectors mediated mouse genetic engineering Tr after allogeneic bone marrow transplantation in mice

[Influence of Mouse Genetic Engineering Regulatory T Cells Infusion on Post-Allogeneic Bone Marrow Transplantation Acute Graft-Versus-host Disease in Mice].

Effect of lethal total body irradiation on bone marrow chimerism, acute graft-versus-host disease, and tumor engraftment in mouse models: impact of different radiation techniques using low- and high-energy X-rays

Effect of different irradiation doses on establishment of murine acute GVHD model after MHC-mismatched transplantation

Influence of the lentiviral vectors-mediated mouse genetic engineering Treg after allogeneic bone marrow transplantation on graft-versus-hostdiseaseinmice

Experimental study on prevention of graft-versus-host disease by selective elimination of alloreactive donor lymphocytes prior to stem cell transplantation

In Vivo Bioluminescence Imaging (Bli) And Sequential 18f]Fhbg Micropet Imaging Studies Of Human T Cell (Hut) Trafficking, Expansion And Xenogeneic Graft-Versus-Host-Disease (Xgvhd) Following Different Routes Of T Cell Administration.

IFN-γ Receptor-Deficient Donor T Cells Mediate Protection from Graft-Versus-host Disease and Preserve Graft-Versus-tumor Responses after Allogeneic Bone Marrow Transplantation.

Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients.

Transfusion-associated Graft-Versus-host-disease: Case Report and Review of Literature

[Effect of Different Irradiation Doses on the Establishment of Murine Cgvhd Model after MHC Matched Spleen Stem Cell Transplantation].

Selective elimination of alloreactive donor lymphocytes by using TBI and cyclophosphamide]

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull mice

Effect of recipient mouse splenocytes taken orally by donor mouse on GVHD after splenocyte transplantation]

Induction of acute graft vs. host disease in lymphopenic mice

382: Β2 Intergrins Separates Graft-versus-host Disease and Graft-versus-leukemia Effect

Irradiation of Peripheral Blood Mononuclear Cells with 7.5 Gy X-rays Prior to Donor Lymphocyte Infusion Inhibits Proliferation While Preserving Cytotoxicity, and Improves the Effectiveness of HSCT in Patients with Hematological Malignancies

Development of transfusion associated graft vs host disease model by allogeneic splenocytes infusion